![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, March 11, 2017 1:58:48 PM
Pfizer is a very good producer, not that I would say they're in the upper echelon, but not far behind.
When they announce their acquisition of Hospira I think I even mentioned on IH that it really is a step backwards for Pfizer. What we're seeing in Kansas is that "Old Habits" are really hard to break.
Hospira's niche always was basically as a hospital supply company dealing in the items you'd see in a operating or hospital room. Saline's, infusion pumps, monitoring equipment etc. They eventually were forced to be a low cost producer because price mattered when going against foreign producers.
Hospira still has to operate in a low cost environment so Pfizer's higher cost policies constantly collide together.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM